Pancreatitis Trial, Recruiting NCT03977779 Sponsor: Institut Paoli-Calmettes Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT03977779
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age
  • People who are considered at risk of developing pancreatitis (inflammation of the pancreas) after a procedure called ERCP (a procedure that examines the bile ducts and pancreatic duct), based on factors related to either the procedure itself or the patient's individual health profile

Who may not be able to join:

  • Women who are pregnant or breastfeeding
  • People who have been diagnosed with acute pancreatitis (sudden inflammation of the pancreas) within the past month
  • People for whom an endoscopy procedure (a procedure involving a camera-equipped tube inserted into the body) is not considered safe or appropriate
  • People who have a known allergy or sensitivity to the medication indomethacin

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33491223778

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institut Paoli-Calmettes
Registry
ClinicalTrials.gov
Start date
20 January 2022
Est. completion
1 December 2024

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Percentage of patients with a complete clearance of the biodegradable stent

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov